BMJ Clinical Evidence is one of the world's most authoritative medical resources for informing treatment decisions and improving patient care.
Latest updated reviews
- Otitis externa (updated)
- Chlamydia (uncomplicated, genital) (updated)
- GORD in adults (updated)
- Bulimia nervosa (updated)
- Diabetes: foot ulcers/amputation (updated)
- Common cold (updated)
- Diabetes: managing dyslipidaemia (updated)
- Preterm birth (updated)
- Tennis elbow (updated)
- Summary of all updates
Editorial
Strategies to reduce morbidity and mortality from postpartum haemorrhage in resource-poor settings are determined by the resources available to a community. But does the evidence support the strategies implemented? In our Guest Editorial, Metin Gülmezoglu and Justus Hofmeyr review gaps in the evidence, and suggest that focusing on community interventions could be the way forward.
Drug safety alerts
- FDA issues drug safety alert on increased risk of cancer mortality associated with use of 3 or more tubes of becaplermin (09 June 2008).
- Long term use of thiazolidinediones linked to increased fracture risk.
(29 April 2008) - FDA issues drug safety alert on neuropsychiatric events (delirium and abnormal behaviour leading to injury) associated with oseltamivir.
(4 March 2008)
Our methods
The systematic reviews in BMJ Clinical Evidence result from a rigorous process aimed at ensuring that they are both reliable and relevant to clinical practice.
Learn about our methods.
Consultancy reviews
Smoking cessation
We present a new review on an evidence-based approach to Smoking cessation.
Managing HIV infection
View our systematic reviews on the challenges of managing HIV/AIDS in resource-poor settings.
July 4, 2008
News Feeds & Email Alerts
Activate your subscription
Handbook & Online subscribers:
Activate your online account
BMJ Clinical Evidence Userguide
Articles and Research section
Access the latest independent research on BMJ Clinical Evidence
BMJ Clinical Evidence Research Report
Evidence in Practice Newsletter
